Risch A - Search Results

1

Chromosomal localization of human genes for arylamine N-acetyltransferase.

Hickman D, Risch A, Buckle V, Spurr NK, Jeremiah SJ, McCarthy A, Sim E. Hickman D, et al. Among authors: risch a. Biochem J. 1994 Feb 1;297 ( Pt 3)(Pt 3):441-5. doi: 10.1042/bj2970441. Biochem J. 1994. PMID: 8110178 Free PMC article.

2

Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants.

Hickman D, Risch A, Camilleri JP, Sim E. Hickman D, et al. Among authors: risch a. Pharmacogenetics. 1992 Oct;2(5):217-26. doi: 10.1097/00008571-199210000-00004. Pharmacogenetics. 1992. PMID: 1306121

3

Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer.

Risch A, Wallace DM, Bathers S, Sim E. Risch A, et al. Hum Mol Genet. 1995 Feb;4(2):231-6. doi: 10.1093/hmg/4.2.231. Hum Mol Genet. 1995. PMID: 7757072

4

Xenogenetics in multifactorial disease susceptibility.

Sim E, Stanley LA, Risch A, Thygesen P. Sim E, et al. Among authors: risch a. Trends Genet. 1995 Dec;11(12):509-12. doi: 10.1016/s0168-9525(00)89162-3. Trends Genet. 1995. PMID: 8533169 Review.

5

Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients.

Risch A, Smelt V, Lane D, Stanley L, van der Slot W, Ward A, Sim E. Risch A, et al. Pharmacol Toxicol. 1996 Apr;78(4):235-40. doi: 10.1111/j.1600-0773.1996.tb00211.x. Pharmacol Toxicol. 1996. PMID: 8861781 Clinical Trial.

6

Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours.

Matas N, Thygesen P, Stacey M, Risch A, Sim E. Matas N, et al. Among authors: risch a. Cytogenet Cell Genet. 1997;77(3-4):290-5. doi: 10.1159/000134601. Cytogenet Cell Genet. 1997. PMID: 9284941

7

Genes for human arylamine N-acetyltransferases in relation to loss of the short arm of chromosome 8 in bladder cancer.

Thygesen P, Risch A, Stacey M, Fakis G, Giannoulis F, Takle L, Knowles M, Sim E. Thygesen P, et al. Among authors: risch a. Pharmacogenetics. 1999 Feb;9(1):1-8. doi: 10.1097/00008571-199902000-00001. Pharmacogenetics. 1999. PMID: 10208636

8

Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide.

Mongey AB, Sim E, Risch A, Hess E. Mongey AB, et al. Among authors: risch a. J Rheumatol. 1999 Aug;26(8):1721-6. J Rheumatol. 1999. PMID: 10451068

9

Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.

Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK, Golka K, Okkels H, Risch A, Rothman N, Sim E, Taioli E. Vineis P, et al. Among authors: risch a. Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1249-52. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11751441

10

Arylarnine N-acetyltransferase as a potential biornarker in bladder cancer: fluorescent in situ hybridization and irnmunohistochernistry studies.

Stacey M, Thygesen P, Stanley L, Matas N, Risch A, Sim E. Stacey M, et al. Among authors: risch a. Biomarkers. 1996;1(1):55-61. doi: 10.3109/13547509609079347. Biomarkers. 1996. PMID: 23888894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters